Consistent with this prediction, in long-term culture initiating cell (LTC-IC) assays, an in vitro measure of HSPC activity that also correlates with survival in human AML42, HMGN1-OE plus AML-ETO9a leukemias had increased colony formation capacity (Fig. 5h). The gene discussed is HMGN1; the disease is acute myeloid leukemia.